Erlotinib metaboliseres i leveren af de hepatiske, humane cytokromer, primært af CYP3A4 og i mindre udstrækning af CYP1A2.
Erlotinib is metabolised in the liver by the hepatic cytochromes in humans, primarily CYP3A4 and to a lesser extent by CYP1A2.